newsfilter
← Latest News
PR Newswire·

Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial...